US$ 22.25
heart failure glp 1 Effects of Glucagon-Like Peptide Receptor Agonist Initiation in Patients With With Reduced Ejection Fraction and Implantable Cardiac Devices GLP-1 and the cardiovascular system
Description
Assessment of the pharmacokinetic interaction between the novel DPP-4 inhibitor linagliptin and a sulfonylurea, glyburide, in healthy subjects

The purpose of this paper is to critically examine the inconsistencies of currently published data, examine the appropriateness of the current guidelines and to further educate anesthesiologists on the importance of informed perioperative assessment and management of these patients

R.YangB

Selby A, Reichenbach ZW, Piech G, Friedenberg FK
Il contribue au diagnostic, au suivi thrapeutique et la lutte contre les grandes endmies (VIH, tuberculose, paludisme) dans la Rgion Centrale du Togo
